Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$379M Buy
1,076,357
+4,964
+0.5% +$1.77M 0.44% 39
2025
Q4
$351M Buy
1,071,393
+18,222
+2% +$5.78M 0.42% 39
2025
Q3
$297M Buy
1,053,171
+16,031
+2% +$4.65M 0.38% 44
2025
Q2
$290M Buy
1,037,140
+22,221
+2% +$6.3M 0.42% 40
2025
Q1
$316M Buy
1,014,919
+100,539
+11% +$29.7M 0.53% 37
2024
Q4
$238M Buy
914,380
+19,250
+2% +$5.71M 0.4% 43
2024
Q3
$288M Sell
895,130
-1,738
-0.2% -$569K 0.51% 36
2024
Q2
$280M Buy
896,868
+47,537
+6% +$14M 0.54% 32
2024
Q1
$241M Buy
849,331
+65,979
+8% +$19.3M 0.5% 37
2023
Q4
$226M Buy
783,352
+45,265
+6% +$12.3M 0.54% 35
2023
Q3
$198M Buy
738,087
+109,078
+17% +$27.2M 0.53% 35
2023
Q2
$140M Buy
629,009
+246,891
+65% +$57.3M 0.37% 60
2023
Q1
$92.4M Buy
382,118
+149,710
+64% +$36.7M 0.27% 80
2022
Q4
$61M Buy
232,408
+15,807
+7% +$4.24M 0.2% 109
2022
Q3
$48.8M Buy
216,601
+6,457
+3% +$1.57M 0.2% 122
2022
Q2
$51.1M Sell
210,144
-2,506
-1% -$614K 0.21% 116
2022
Q1
$51.4M Buy
212,650
+59,919
+39% +$13.8M 0.19% 117
2021
Q4
$34.4M Buy
152,731
+75,664
+98% +$16M 0.15% 156
2021
Q3
$16.4M Buy
77,067
+18,157
+31% +$4.18M 0.09% 214
2021
Q2
$14.4M Buy
58,910
+8,077
+16% +$1.99M 0.09% 206
2021
Q1
$12.6M Sell
50,833
-7,740
-13% -$1.85M 0.09% 202
2020
Q4
$13.5M Buy
58,573
+6,318
+12% +$1.46M 0.1% 189
2020
Q3
$13.3M Buy
52,255
+872
+2% +$216K 0.13% 170
2020
Q2
$12.1M Buy
51,383
+6,131
+14% +$1.4M 0.12% 171
2020
Q1
$9.17M Buy
45,252
+7,574
+20% +$1.65M 0.11% 175
2019
Q4
$9.08M Buy
37,678
+2,355
+7% +$519K 0.09% 198
2019
Q3
$6.83M Sell
35,323
-10,453
-23% -$2.01M 0.08% 208
2019
Q2
$8.44M Buy
45,776
+2,316
+5% +$415K 0.1% 194
2019
Q1
$8.26M Sell
43,460
-42,152
-49% -$8.05M 0.12% 180
2018
Q4
$16.7M Buy
85,612
+51,296
+149% +$10M 0.3% 101
2018
Q3
$7.11M Buy
34,316
+2,433
+8% +$479K 0.18% 128
2018
Q2
$5.88M Buy
31,883
+16,018
+101% +$2.83M 0.17% 133
2018
Q1
$2.7M Sell
15,865
-13,017
-45% -$2.39M 0.1% 178
2017
Q4
$5.02M Buy
28,882
+18,630
+182% +$3.3M 0.19% 99
2017
Q3
$1.91M Sell
10,252
-178
-2% -$31.5K 0.09% 179
2017
Q2
$1.8M Sell
10,430
-5,821
-36% -$947K 0.08% 182
2017
Q1
$2.67M Buy
16,251
+445
+3% +$73.9K 0.12% 154
2016
Q4
$2.31M Buy
15,806
+692
+5% +$104K 0.11% 166
2016
Q3
$2.52M Buy
15,114
+4,159
+38% +$703K 0.12% 154
2016
Q2
$1.67M Buy
10,955
+2,551
+30% +$397K 0.09% 191
2016
Q1
$1.26M Buy
8,404
+2,098
+33% +$312K 0.07% 215
2015
Q4
$1.02M Sell
6,306
-915
-13% -$144K 0.07% 209
2015
Q3
$999K Sell
7,221
-12,419
-63% -$1.96M 0.04% 246
2015
Q2
$3.02M Buy
19,640
+14,398
+275% +$2.31M 0.14% 137
2015
Q1
$838K Buy
5,242
+1,498
+40% +$236K 0.07% 197
2014
Q4
$596K Sell
3,744
-1,602
-30% -$250K 0.05% 221
2014
Q3
$751K Buy
5,346
+497
+10% +$64.9K 0.08% 171
2014
Q2
$574K Buy
4,849
+870
+22% +$101K 0.06% 212
2014
Q1
$491K Sell
3,979
-1,239
-24% -$150K 0.06% 214
2013
Q4
$595K Buy
5,218
+504
+11% +$57.3K 0.07% 210
2013
Q3
$528K Buy
+4,714
New +$511K 0.1% 185

Other funds holding AMGN

Mariner's AMGN Position: Q1 2026 in Review

Mariner increased its Amgen (AMGN) stake by 0.46% in Q1 2026, buying an estimated $1.77M and bringing the position to 1,076,357 shares worth $379M. The position accounts for 0.44% of the portfolio, ranked #39.

Mariner first reported a position in AMGN in Q3 2013 and has held it in 51 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Mariner held 1,076,357 shares of Amgen worth $379M as of Q1 2026.
  • Mariner bought 4,964 Amgen shares in Q1 2026, an estimated $1.77M.
  • Amgen made up 0.44% of Mariner's portfolio in Q1 2026, its #39 holding.
  • Mariner first reported a position in Amgen in Q3 2013 and has held it in 51 quarters since.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.